BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 35965320)

  • 1. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.
    Mononen M; Saari E; Hasala H; Kettunen HP; Suoranta S; Nurmi H; Kärkkäinen M; Selander T; Randell J; Laurikka J; Uibu T; Koskela H; Kaarteenaho R; Purokivi M
    BMC Pulm Med; 2022 Aug; 22(1):313. PubMed ID: 35965320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
    Adegunsoye A; Oldham JM; Bellam SK; Montner S; Churpek MM; Noth I; Vij R; Strek ME; Chung JH
    Ann Am Thorac Soc; 2019 May; 16(5):580-588. PubMed ID: 30653927
    [No Abstract]   [Full Text] [Related]  

  • 6. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Chung JH; Cox CW; Montner SM; Adegunsoye A; Oldham JM; Husain AN; Vij R; Noth I; Lynch DA; Strek ME
    AJR Am J Roentgenol; 2018 Feb; 210(2):307-313. PubMed ID: 29140119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.
    Salisbury ML; Xia M; Murray S; Bartholmai BJ; Kazerooni EA; Meldrum CA; Martinez FJ; Flaherty KR
    Respir Med; 2016 Sep; 118():88-95. PubMed ID: 27578476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-life prevalence of progressive fibrosing interstitial lung diseases.
    Gagliardi M; Berg DV; Heylen CE; Koenig S; Hoton D; Tamirou F; Pieters T; Ghaye B; Froidure A
    Sci Rep; 2021 Dec; 11(1):23988. PubMed ID: 34907290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria.
    Yamakawa H; Sato S; Tsumiyama E; Nishizawa T; Kawabe R; Oba T; Kamikawa T; Horikoshi M; Akasaka K; Amano M; Kuwano K; Matsushima H
    J Thorac Dis; 2019 Dec; 11(12):5247-5257. PubMed ID: 32030242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nintedanib by inclusion criteria for progression of interstitial lung disease.
    Maher TM; Brown KK; Kreuter M; Devaraj A; Walsh SLF; Lancaster LH; Belloli EA; Padilla M; Behr J; Goeldner RG; Tetzlaff K; Schlenker-Herceg R; Flaherty KR;
    Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34210788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The updated S2k guideline for the diagnosis of idiopathic pulmonary fibrosis : Essential aspects for pathology].
    Fink L; Jonigk D
    Pathologe; 2021 Feb; 42(1):40-47. PubMed ID: 33416935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Clinical Measures Among Interstitial Lung Disease (ILD) Patients with Usual Interstitial Pneumonia (UIP) Patterns on High-Resolution Computed Tomography.
    Gibson CD; Bhatt A; Deshwal H; Li X; Goldberg JD; Ko J; Condos R
    Lung; 2020 Oct; 198(5):811-819. PubMed ID: 32889595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution computed tomography patterns in interstitial lung disease (ILD): prevalence and prognosis.
    Almeida RF; Watte G; Marchiori E; Altmayer S; Pacini GS; Barros MC; Paza Junior A; Runin AS; Salem MCGG; Hochhegger B
    J Bras Pneumol; 2020; 46(5):e20190153. PubMed ID: 32159601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment.
    Kondoh Y; Taniguchi H; Ogura T; Johkoh T; Fujimoto K; Sumikawa H; Kataoka K; Baba T; Colby TV; Kitaichi M
    Respirology; 2013 Jul; 18(5):820-6. PubMed ID: 23489318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease.
    Niitsu T; Fukushima K; Komukai S; Takata S; Abe Y; Nii T; Kuge T; Iwakoshi S; Shiroyama T; Miyake K; Tujino K; Tanizaki S; Iwahori K; Hirata H; Miki K; Yanagawa M; Takeuchi N; Takeda Y; Kida H; Kumanogoh A
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36690385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
    Arcadu A; Byrne SC; Pirina P; Hartman TE; Bartholmai BJ; Moua T
    Respir Med; 2017 Aug; 129():152-157. PubMed ID: 28732823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.
    Raghu G; Wells AU; Nicholson AG; Richeldi L; Flaherty KR; Le Maulf F; Stowasser S; Schlenker-Herceg R; Hansell DM
    Am J Respir Crit Care Med; 2017 Jan; 195(1):78-85. PubMed ID: 27331880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.
    Raghu G; Mageto YN; Lockhart D; Schmidt RA; Wood DE; Godwin JD
    Chest; 1999 Nov; 116(5):1168-74. PubMed ID: 10559072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.
    Chung JH; Adegunsoye A; Cannon B; Vij R; Oldham JM; King C; Montner SM; Thirkateh P; Barnett S; Karwoski R; Bartholmai BJ; Strek M; Nathan SD
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34204184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.